Skip Navigation LinksHome > Sign Up
Sign up

Sign Up


When you join Cornerstones4Care®, you will have access to the Cornerstones4Care® Diabetes Health Coach program—a step-by-step, customized learning and action plan to help you build the healthy habits and skills you need to manage your diabetes. It features:

  • Online coaching sessions and videos on topics that matter to you
  • Tools and trackers to monitors your progress
  • Tips and reminders to help you at every step
To get started, please answer the questions below.

Tell us about yourself.

*Required fields

What best describes you?*

Click on the icon that applies to you.

What type of diabetes do you have?*

Click on the icon that applies to you.

Must be 8 characters or more, contain at least 1 capital letter, 1 number, and 1 special character (such as !,#,$,%).

Periodically, we may send information by mail. Please provide your address.

Because you are younger than 18 years old, please have a parent or guardian complete the fields below.

What medications do you take? How long have you taken them?*

Add another medication

Please provide your phone number and check the box below if you are interested in receiving calls from a diabetes educator.

*Are you enrolled in any government, state, or federally funded medical or prescription benefit programs? This includes Medicare, Medicaid, Medigap, VA, DOD, and TRICARE, as well as any other state or federal employee benefit programs.

You are not eligable for this discount offer. Please complete your registration for access to other program benefits.

*The Instant Savings Card is not valid for prescriptions purchased under Medicaid, Medicare, or similar federal, state, or government-funded benefit programs. If eligible, I understand that certain information pertaining to my use of the Card will be shared by my pharmacy with Novo Nordisk, the sponsor of the Card. The information disclosed will include the date I filled the prescription, amount of medication dispensed by my pharmacist, and amount I will be reimbursed by Novo Nordisk. Should I begin receiving prescription benefits from a federal, state, or other government-funded program at any time, I will no longer be eligible to participate in this program. You may contact me by phone or mail periodically in order to verify that my eligibility for the program has not changed.

You are not eligable for this discount offer. Please complete your registration for access to other program benefits.

Novo Nordisk Inc. (“Novo Nordisk”) understands protecting your personal and health information is very important. We do not share any personally identifiable or health information you give us with third parties for their own marketing use.

I understand from time to time, Novo Nordisk’s Privacy Policy may change and for the most recent version of the Privacy Policy, I should click here.

By checking “I Agree” and clicking "Continue," I consent that the information I am providing may be used by Novo Nordisk, its affiliates or vendors to keep me informed about products, patient support services, special offers, or other opportunities that may be of interest to me via mail, e-mail, or phone. Novo Nordisk may also combine the information I provide with information from third parties to better match these offers with my interests. These materials may contain information that market or advertise Novo Nordisk products, goods, or services. I may opt-out at any time by clicking the unsubscribe link within any e-mail I receive, by calling 1-877-744-2579, or by sending a letter with my request to Novo Nordisk Inc., 800 Scudders Mill Road, Plainsboro, New Jersey, 08536 USA.

To register, users must be at least 13 years old, and users who are between ages 13-17 must have a parent’s permission to participate. By checking “I Agree” and clicking "Continue" I am agreeing to Novo Nordisk’s Privacy Policy; and I also affirm that I am either 18 years of age or older, or that I am 13–17 years of age and have my parent’s permission to participate. Novo Nordisk does not knowingly collect, use, or disclose personally identifiable information from anyone under the age of 13. Parents with any concerns or complaints should contact Novo Nordisk at 1-877-744-2579.

You must check the “I Agree” box and click "Continue" to complete your registration. If you do not agree to the terms above, you may exit out of this page and we invite you to explore other areas of the site without registering. You may return to this page at any time to register.

Next step: Tell us a little about yourself so we can point you to the information you care about.

Trouble registering? Contact Us for support.
 

Indications and Usage for Victoza®

Victoza® (liraglutide [rDNA origin] injection) is an injectable prescription medicine that may improve blood sugar (glucose) in adults with type 2 diabetes when used along with diet and exercise.

Victoza® is not recommended as the first medication to treat diabetes. Victoza® has not been studied in patients with history of inflammation of the pancreas (pancreatitis). Victoza® is not a substitute for insulin and has not been studied in combination with prandial (mealtime) insulin. Victoza® is not for people with type 1 diabetes or people with diabetic ketoacidosis. It is not known if Victoza® is safe and effective in children. Victoza® is not recommended for use in children.

Important Safety Information for Victoza®

In animal studies, Victoza® caused thyroid tumors—including thyroid cancer—in some rats and mice. It is not known whether Victoza® causes thyroid tumors or a type of thyroid cancer called medullary thyroid cancer (MTC) in people, which may be fatal if not detected and treated early. Do not use Victoza® if you or any of your family members have a history of MTC or if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). While taking Victoza®, tell your doctor if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer.

Do not use Victoza® if you are allergic to liraglutide or any of the ingredients in Victoza®. Serious allergic reactions can happen with Victoza®. If symptoms of serious allergic reactions occur, stop taking Victoza® and seek medical attention. Pancreatitis may be severe and lead to death. Before taking Victoza®, tell your doctor if you have had pancreatitis, gallstones, a history of alcoholism, or high blood triglyceride levels since these medical conditions make you more likely to get pancreatitis.

Stop taking Victoza® and call your doctor right away if you have pain in your stomach area that is severe and will not go away, occurs with or without vomiting, or is felt going from your stomach area through to your back. These may be symptoms of pancreatitis.

Before using Victoza®, tell your doctor about all the medicines you take, especially sulfonylurea medicines or insulin, as taking them with Victoza® may affect how each medicine works. If you use Victoza® with insulin, you may give both injections in the same body area (for example, your stomach area), but not right next to each other.

Also tell your doctor if you have severe stomach problems such as slowed emptying of your stomach (gastroparesis) or problems with digesting food; have or have had kidney or liver problems; have any other medical conditions; or are pregnant or plan to become pregnant. Tell your doctor if you are breastfeeding or plan to breastfeed. It is unknown if Victoza® will harm your unborn baby or if Victoza® passes into your breast milk.

Your risk for getting hypoglycemia, or low blood sugar, is higher if you take Victoza® with another medicine that can cause low blood sugar, such as a sulfonylurea or insulin. The dose of your sulfonylurea medicine or insulin may need to be lowered while taking Victoza®.

Victoza® may cause nausea, vomiting, or diarrhea leading to dehydration, which may cause kidney failure. This can happen in people who have never had kidney problems before. Drinking plenty of fluids may reduce your chance of dehydration.

The most common side effects with Victoza® include headache, nausea, and diarrhea. Nausea is most common when first starting Victoza®, but decreases over time in most people. Immune system related reactions, including hives, were more common in people treated with Victoza® compared to people treated with other diabetes drugs in medical studies.

Please click here for Victoza® Prescribing Information.

Victoza® is a prescription medicine.

Indications and Usage for Levemir®

What is Levemir® (insulin detemir [rDNA origin] injection)?

  • Levemir® is a man-made insulin used to control high blood sugar in adults and children with diabetes mellitus.
  • Levemir® is not meant for use to treat diabetic ketoacidosis.

Important Safety Information for Levemir®

Who should not take Levemir®?

Do not take Levemir® if:

  • you have an allergy to Levemir® or any of the ingredients in Levemir®.

Before taking Levemir®, tell your health care provider about all your medical conditions including, if you are:

  • pregnant, plan to become pregnant, or are breastfeeding.
  • taking new prescription or over-the-counter medicines, including supplements.

Talk to your health care provider about how to manage low blood sugar.

How should I take Levemir®?

  • Read the Instructions for Use and take exactly as directed.
  • Know the type and strength of your insulin. Do not change your insulin type unless your health care provider tells you to.
  • Check your blood sugar levels. Ask your health care provider what your blood sugar levels should be and when you should check them.
  • Do not share needles, insulin pens, or syringes. You may give or get an infection from another person.
  • Never inject Levemir® into a vein or muscle.

What should I avoid while taking Levemir®?

  • Do not drive or operate heavy machinery, until you know how it affects you.
  • Do not drink alcohol or use medicines that contain alcohol.

What are the possible side effects of Levemir®?

Serious side effects can lead to death, including:

Low blood sugar. Some signs and symptoms include:

  • anxiety, irritability, mood changes, dizziness, sweating, confusion, and headache.

Your insulin dose may need to change because of:

  • change in level of physical activity, weight gain or loss, increased stress, illness, or change in diet.

Other common side effects may include:

  • reactions at the injection site, itching, rash, serious allergic reactions (whole body reactions), skin thickening or pits at the injection site (lipodystrophy), weight gain, swelling of your hands and feet and if taken with thiazolidinediones (TZDs) possible heart failure.

Get emergency medical help if you have:

  • trouble breathing, shortness of breath, fast heartbeat, swelling of your face, tongue, or throat, sweating, extreme drowsiness, dizziness, or confusion.

Please click here for Levemir® Prescribing Information.

Levemir® is a prescription medicine.

Indications and Usage

What is NovoLog® (insulin aspart [rDNA origin] injection)?

  • NovoLog® is a man-made insulin used to control high blood sugar in adults and children with diabetes mellitus.

Important Safety Information for NovoLog®

Who should not take NovoLog®?

Do not take NovoLog® if:

  • your blood sugar is too low (hypoglycemia) or you are allergic to any of its ingredients.

Before taking NovoLog®, tell your health care provider about all your medical conditions including, if you are:

  • pregnant, plan to become pregnant, or are breastfeeding.
  • taking new prescription or over-the-counter medicines, including supplements.

Talk to your health care provider about how to manage low blood sugar.

How should I take NovoLog®?

  • Read the Instructions for Use and take exactly as directed.
  • NovoLog® is fast-acting. Eat a meal within 5 to 10 minutes after taking it.
  • Know the type and strength of your insulin. Do not change your insulin type unless your health care provider tells you to.
  • Check your blood sugar levels. Ask your health care provider what your blood sugar levels should be and when you should check them.
  • Do not share your NovoLog® FlexPen® or FlexTouch®, PenFill cartridge or PenFill cartridge device with another person, even if the needle is changed. Do not reuse or share needles with another person. You may give another person an infection or get an infection from them.

What should I avoid while taking NovoLog®?

  • Do not drive or operate heavy machinery, until you know how NovoLog® affects you.
  • Do not drink alcohol or use medicines that contain alcohol.

What are the possible side effects of NovoLog®?

Serious side effects can lead to death, including:

Low blood sugar. Some signs and symptoms include:

  • anxiety, irritability, mood changes, dizziness, sweating, confusion, and headache.

Your insulin dose may need to change because of:

  • weight gain or loss, increased stress, illness, or change in diet or level of physical activity.

Other common side effects may include:

  • low potassium in your blood, injection site reactions, itching, rash, serious whole body allergic reactions, skin thickening or pits at the injection site, weight gain, and swelling of your hands and feet and if taken with thiazolidinediones (TZDs) possible heart failure.

Get emergency medical help if you have:

  • trouble breathing, shortness of breath, fast heartbeat, swelling of your face, tongue, or throat, sweating, extreme drowsiness, dizziness, or confusion.

For more information, please click here for complete NovoLog® Prescribing Information.

NovoLog® is a prescription medicine.

Talk to your doctor about the importance of diet and exercise in your treatment plan.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

PPA Logo Rev
If you need assistance with prescription drug costs, help may be available. Visit pparx.org or call 1-888-4PPA-NOW.

Indications and Usage for NovoLog® Mix 70/30

What is NovoLog® Mix 70/30 (70% insulin aspart protamine suspension and 30% insulin aspart injection, [rDNA origin])?

  • NovoLog® Mix 70/30 is a man-made insulin used to control high blood sugar in adults with diabetes mellitus.
  • It is not known if NovoLog® Mix 70/30 is safe or effective in children.

Important Safety Information for NovoLog® Mix 70/30

Who should not use NovoLog® Mix 70/30?

  • Do not use NovoLog® Mix 70/30 if your blood sugar is too low (hypoglycemia) or you are allergic to any of its ingredients.

What should I tell my health care provider before taking NovoLog® Mix 70/30?

  • About all of your medical conditions, including liver, kidney, or heart problems.
  • If you are pregnant, breastfeeding, or plan to do either.
  • About all prescription and nonprescription medicines you take, including supplements, as your dose may need to change.

How should I take NovoLog® Mix 70/30?

  • NovoLog® Mix 70/30 starts acting fast. If you have type 1 diabetes, inject within 15 minutes before you eat a meal. If you have type 2 diabetes, inject within 15 minutes before or after starting your meal.
  • Inject NovoLog® Mix 70/30 under the skin of your stomach area, upper arms, buttocks, or thighs, but never into a vein or muscle.
  • Do not mix NovoLog® Mix 70/30 with other insulin products or use in an insulin pump.
  • Do not change your dose or type of insulin unless you are told to by your health care provider.
  • Do not share needles, insulin pens, or syringes.
  • Check your blood sugar levels as directed by your health care provider.

What should I consider while using NovoLog® Mix 70/30?

  • Alcohol, including beer and wine, may affect your blood sugar.
  • Be careful when driving a car or operating machinery. You may have difficulty concentrating or reacting if you have low blood sugar. Talk to your health care provider if you often have low blood sugar or no warning signs of low blood sugar.

What are the possible side effects of NovoLog® Mix 70/30?

  • Low blood sugar, including when too much is taken. Some symptoms include sweating, shakiness, confusion, and headache. Severe low blood sugar can cause unconsciousness, seizures, and death.
  • Serious allergic reactions may occur. Get medical help right away, if you develop a rash over your whole body, have trouble breathing, a fast heartbeat, or sweating.
  • Other side effects include low potassium in your blood, injection site reactions (like redness, swelling, and itching), skin thickening or pits at the injection site, weight gain, swelling of your hands and feet, if taken with thiazolidinediones (TZDs) possible heart failure, and vision changes.

Please click here for NovoLog® Mix 70/30 Prescribing Information.

NovoLog® Mix 70/30 is a prescription medicine.

Talk to your doctor about the importance of diet and exercise in your treatment plan.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

PPA Logo Rev
If you need assistance with prescription drug costs, help may be available. Visit pparx.org or call 1-888-4PPA-NOW.

 

Levemir®, Novolin®, NovoLog®, and Victoza® are registered trademarks of Novo Nordisk A/S. Bydureon® and Byetta® are registered trademarks of the AstraZeneca group of companies. Humalog® and Humulin® are registered trademarks of Eli Lilly and Company. Apidra® and Lantus® are registered trademarks of sanofi-aventis U.S. LLC.

This website is intended for use by United States residents only. The content is for informational purposes only and is not intended to replace a discussion with a health care provider.

Email to a Friend2:

email icon

To(;):

From:

Message: